cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biomarin Pharmaceutical Inc
43 own
21 watching
Current Price
$0
$-0.74
(-0.66%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
20,968.41M
52-Week High
52-Week High
117.77
52-Week Low
52-Week Low
70.73
Average Volume
Average Volume
0.75M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
965.9684
iconMarket Capitalization20,968.41M
icon52-Week High117.77
icon52-Week Low70.73
iconAverage Volume0.75M
iconDividend Yield--
iconP/E Ratio965.9684
What does the Biomarin Pharmaceutical Inc do?
BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Its commercial products include Aldurazyme used for the treatment of patients with mucopolysaccharidosis I, a genetic disease; Kuvan, a proprietary synthetic oral form of 6R-BH4 used to treat patients with phenylketonuria (PKU), an inherited metabolic disease; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; and Vimizim, an enzyme replacement therapy for the treatment of MPS IV A, a lysosomal storage disorder. The company also conducts clinical trials on several investigational product candidates for the treatment of various diseases, including Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis, a form of Batten disease; pegvaliase, an enzyme substitution therapy for the treatment of PKU; vosoritide, a peptide therapeutic for the treatment of achondroplasia; BMN 270, an AAV VIII vector and Factor VIII gene therapy drug development candidate, for the treatment of hemophilia A; and BMN 250, a novel fusion of alpha-N-acetyglucosaminidase for the treatment of Sanfilippo B syndrome, or mucopolysaccharidosis type IIIB. The company serves specialty pharmacies and end-users, such as hospitals and foreign government agencies; and distributors and pharmaceutical wholesalers. BioMarin Pharmaceutical Inc. has a collaboration agreement with Genzyme Corporation. The company was founded in 1996 and is headquartered in San Rafael, California.
Read More
How much money does Biomarin Pharmaceutical Inc make?
News & Events about Biomarin Pharmaceutical Inc.
Zolmax
4days ago
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN Get Rating) EVP Jeffrey Robert Ajer sold 49,000 shares of the companys stock in a transaction dated Wednesday, January 25th. The shares were sold at an average price of $115.70, for a total value of $5,669,300.00. Following the completion of ...
Zolmax
9days ago
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN Get Rating) has earned an average rating of Moderate Buy from the nineteen research firms that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on ...
Ticker Report
13days ago
Canaccord Genuity Group began coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN Get Rating) in a report published on Wednesday, Marketbeat reports. The brokerage issued a hold rating and a $119.00 target price on the biotechnology companys stock. Several other equities ...
PR Newswire
26days ago
BioMarin Announces Stable and Durable Annualized Bleed Control for ROCTAVIAN in Largest Phase 3 Gene Therapy Study in Adults with Severe Hemophilia A; 134-Participant Study Met All Primary and Secondary Efficacy Endpoints at 3-Year Analysis BioMarin Announces Stable and Durable Annualized Bleed...
PR Newswire
29days ago
Thinking about trading options or stock in Biomarin Pharmaceutical, Docusign, Apple, MicroStrategy, or Allstate Corp? Thinking about trading options or stock in Biomarin Pharmaceutical, Docusign, Apple, MicroStrategy, or Allstate Corp? PR Newswire NEW YORK, Jan. 5, 2023 NEW YORK, Jan. 5, 2023...
Frequently Asked Questions
Frequently Asked Questions
What is Biomarin Pharmaceutical Inc share price today?
plus_minus_icon
Can Indians buy Biomarin Pharmaceutical Inc shares?
plus_minus_icon
How can I buy Biomarin Pharmaceutical Inc shares from India?
plus_minus_icon
Can Fractional shares of Biomarin Pharmaceutical Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biomarin Pharmaceutical Inc stocks?
plus_minus_icon
What is today’s traded volume of Biomarin Pharmaceutical Inc?
plus_minus_icon
What is today’s market capitalisation of Biomarin Pharmaceutical Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biomarin Pharmaceutical Inc?
plus_minus_icon
What percentage is Biomarin Pharmaceutical Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biomarin Pharmaceutical Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.74
(-0.66%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00